NCT06606652View on ClinicalTrials.gov

Caffeine, Resistance Exercise and EMG

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Caffeine
Interventions
DIETARY_SUPPLEMENT

Caffeine

Acute caffeine intake (3 mg/kg)

DIETARY_SUPPLEMENT

Placebo

Acute placebo intake (3 mg/kg of maltodextrin)

Trial Locations (1)

28805

Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá, Alcalá de Henares

All Listed Sponsors
lead

University of Alcala

OTHER

NCT06606652 - Caffeine, Resistance Exercise and EMG | Biotech Hunter | Biotech Hunter